Table 2.
Procedures of the phase 4 clinical trial.
| Procedures | Visits | ||||||||||
|
|
0 | 1 | 2 | 3 | 4 | Washout | 5 | 6 | 7 | 8 | 9 |
| Informed consent | ✓ | —a | — | — | — | — | — | — | — | — | — |
| Inclusion and exclusion | — | ✓ | — | — | — | — | — | ✓ | — | — | — |
| Vein perception | — | ✓ | — | — | — | — | — | ✓ | — | — | — |
| Sequence allocation | ✓ | — | — | — | — | — | — | — | — | — | — |
| Intervention or comparator | — | ✓ | — | — | — | — | — | ✓ | — | — | — |
| Pain assessment | — | ✓ | — | — | — | — | — | ✓ | — | — | — |
| Hemolysis | — | ✓ | — | — | — | — | — | ✓ | — | — | — |
| Skin type assessment | — | ✓ | — | — | — | — | — | — | — | — | — |
aNot applicable.